533.76
-9.93 (-1.83%)
| Penutupan Terdahulu | 543.69 |
| Jumlah Dagangan | 268,663 |
| Harga / Pendapatan (P/E Ke hadapan) | 81.97 |
| Harga / Jualan (P/S) | 9.68 |
| Harga / Buku (P/B) | 23.93 |
| Julat 52 Minggu |
| Margin Keuntungan | -123.38% |
| Margin Operasi (TTM) | -57.79% |
| EPS Cair (TTM) | -17.83 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 16.85% |
| Nisbah Semasa (MRQ) | 5.91 |
| Aliran Tunai Operasi (OCF TTM) | -395.31 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -274.11 M |
| Pulangan Atas Aset (ROA TTM) | -25.56% |
| Pulangan Atas Ekuiti (ROE TTM) | -50.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Madrigal Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 2.00 |
|
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 7.73% |
| % Dimiliki oleh Institusi | 108.28% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |